Oxford Immunotec (OXFD) Misses Q3 EPS by 3c

Oxford Immunotec (NASDAQ: OXFD) reported Q3 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $16.05 million versus the consensus estimate of $33.5 million.

For earnings history and earnings-related data on Oxford Immunotec (OXFD) click here.

You May Also Be Interested In

• H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
• Canterbury Park (CPHC) Misses Q2 EPS by 3c
• Immunome, Inc. (IMNM) Reports Q2 Loss of $0.65